Lidocaine Hci 4%
Over-the-CounterNomes comerciais: Shoe Pain Relief
About This Medication
Topical product applied to the skin for localized treatment and symptom relief.
Princípios Ativos
| Ingrediente | Concentração |
|---|---|
| Lidocaine Hcl | - |
Indicações e Uso
Posologia e Administração
Advertências e Precauções
Warning For external use only Flamable: keep away fom fire or flame When using this product: avoid spraying in eyes; contents under pressure; do not puncture or incinerate; do not store at temperature above 120F Stop use and ask doctor if: condition worsens, or if symptoms persist for more than 7 days, or clear up and reossu again withing few days
Frequently Asked Questions
Uses For temporary relief of foot pain associated with fatigue, minor cuts, minor scrapes, minor skin irritations
Directions For adult use: apply a thin layer to your feet before wearing shoes, and as needed. Do not use more than 3 to 4 times daily
Warning For external use only Flamable: keep away fom fire or flame When using this product: avoid spraying in eyes; contents under pressure; do not puncture or incinerate; do not store at temperature above 120F Stop use and ask doctor if: condition worsens, or if symptoms persist for more than 7 days, or clear up and reossu again withing few days
Lidocaine Hci 4% is available over the counter (OTC) without a prescription.
Similar Topical Products
Browse all Topical products →References & Data Sources
- • DailyMed — Lidocaine Hci 4% drug label (National Library of Medicine)
- • openFDA — Lidocaine Hci 4% label data (U.S. Food & Drug Administration)
- • NDC Directory — Lidocaine Hci 4% (FDA National Drug Code)
Aviso Médico
As informações nesta página têm fins exclusivamente educacionais e não devem ser usadas como substituto para aconselhamento médico profissional, diagnóstico ou tratamento.
Sempre busque o aconselhamento do seu médico ou outro profissional de saúde qualificado para quaisquer dúvidas que você possa ter sobre uma condição médica ou medicamento.
Fontes de dados: DailyMed (NLM), openFDA, MFDS